Short answer
Cytek Biosciences, Inc. (CTKB) filed an 8-K current report with the SEC on September 29, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). A&R Bylaws effective September 23, 2026, adopted unanimously by the board.
Cytek Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- A&R Bylaws effective September 23, 2026, adopted unanimously by the board
- Expanded disclosure, ownership, solicitation and certification requirements for stockholder proposals and director nominees
- Broader chairperson authority to reject non-compliant nominations and proposals
- Added Rule 14a-19 universal proxy compliance, affecting contested director elections
- New special-meeting nomination procedures and updated virtual-meeting stockholder-list requirements
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cytek Biosciences, Inc. 8-K filings
Get the next CTKB 8-K as it lands
Follow CTKB for push alerts, or ask the research agent what this filing means.